These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2896115

  • 1. [Clinical relevance of the determination of TSH-binding inhibitory immunoglobulins (TBII) in patients with immunogenic hyperthyroidism in methimazole therapy].
    Heberling HJ, Bierwolf B, Kuhlmann E, Klugmann T, Dietel P, Fischer S.
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):331-6. PubMed ID: 2896115
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with a radioreceptor assay for TSH-binding inhibiting immunoglobulins (TBII).
    Heberling HJ, Bierwolf B, Lohmann D.
    Exp Clin Endocrinol; 1988 Aug; 91(3):355-61. PubMed ID: 2908034
    [Abstract] [Full Text] [Related]

  • 3. Detectability of thyroid anti-microsomal antibodies, changes in thyroid-stimulating immunoglobulins (TSI) and thyrotropin-binding-inhibiting immunoglobulins (TBII) during methimazole treatment of Graves' disease patients.
    Szabó J, Leövey A, Karányi Z, Várvölgyi C, Fórizs E, Herceg L.
    Acta Med Hung; 1989 Aug; 46(1):23-30. PubMed ID: 2570399
    [Abstract] [Full Text] [Related]

  • 4. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 5. [Clinical value of the determination of TSH-binding inhibitory immunoglobulins (TBII) by a radioreceptor assay].
    Heberling HJ, Bierwolf B, Lohmann D.
    Dtsch Z Verdau Stoffwechselkr; 1986 Nov; 46(5):301-6. PubMed ID: 2879721
    [Abstract] [Full Text] [Related]

  • 6. A study of the change in serum TBII before and after subtotal thyroidectomy for hyperthyroidism.
    Hoshi T.
    Fukushima J Med Sci; 1985 Jun; 31(1):1-16. PubMed ID: 2867960
    [No Abstract] [Full Text] [Related]

  • 7. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS, Zwicker H, Abbott EC, Douglas R, Givner ML, Gupta MK, Lehmann L, Reddy S, Salisbury SR, Shlossberg AH, Tan MH, York SE.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [Abstract] [Full Text] [Related]

  • 8. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M, Minich WB, Willenberg HS, Papewalis C, Seissler J, Feldkamp J, Bergmann A, Scherbaum WA, Morgenthaler NG.
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.
    Hörmann R, Saller B, Müller R, Mann K.
    Klin Wochenschr; 1985 Dec 16; 63(24):1247-52. PubMed ID: 2868149
    [Abstract] [Full Text] [Related]

  • 10. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H, Amino N, Watanabe Y, Aozasa M, Hayashi H, Tachi J, Miyai K.
    J Clin Lab Immunol; 1986 May 16; 20(1):1-6. PubMed ID: 3016274
    [Abstract] [Full Text] [Related]

  • 11. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs.
    Kawai K, Tamai H, Matsubayashi S, Mukuta T, Morita T, Kubo C, Kuma K.
    Clin Endocrinol (Oxf); 1995 Nov 16; 43(5):551-6. PubMed ID: 8548939
    [Abstract] [Full Text] [Related]

  • 12. [The effect of thyrostatic treatment on circulating thyrotropin-receptor antibodies in Basedow's disease].
    Lozanov B, Kirilov G, Ivanova R, Khubaveshki S.
    Vutr Boles; 1990 Nov 16; 29(3):79-84. PubMed ID: 1704667
    [Abstract] [Full Text] [Related]

  • 13. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
    Brokken LJ, Wiersinga WM, Prummel MF.
    J Clin Endocrinol Metab; 2003 Sep 16; 88(9):4135-8. PubMed ID: 12970276
    [Abstract] [Full Text] [Related]

  • 14. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H, Kuwert T, Lohmann T.
    Exp Clin Endocrinol Diabetes; 2004 Apr 16; 112(4):171-4. PubMed ID: 15127319
    [Abstract] [Full Text] [Related]

  • 15. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC, Buiting AM, Karperien M, Ballieux BE, van der Pluijm G, Pereira AM, Romijn JA, Smit JW.
    Clin Endocrinol (Oxf); 2006 Apr 16; 64(4):429-35. PubMed ID: 16584516
    [Abstract] [Full Text] [Related]

  • 16. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y, Matoba N, Miura S, Sakai N, Taira Y.
    World J Surg; 1992 Apr 16; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [Abstract] [Full Text] [Related]

  • 17. Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease.
    Gamstedt A, Wadman B, Karlsson A.
    J Clin Endocrinol Metab; 1986 Apr 16; 62(4):773-7. PubMed ID: 2869050
    [Abstract] [Full Text] [Related]

  • 18. Clinical value of thyrotropin binding inhibiting immunoglobulins (TBII) assay in hyperthyroidism.
    Duron F, Talbot JN, Féron R, Aubert P, Milhaud G.
    Biomed Pharmacother; 1987 Apr 16; 41(7):383-8. PubMed ID: 2895672
    [Abstract] [Full Text] [Related]

  • 19. Detection of tsh binding inhibiting antibodies (TBI-ab) and thyroid adenylate cyclase stimulating antibodies (TS-ab) in sera of patients with Graves' disease.
    Lattanzi V, Scardapane R, Ciampolillo A, Vincenti C, Giorgino R.
    Boll Soc Ital Biol Sper; 1985 Jan 30; 61(1):55-60. PubMed ID: 3838478
    [Abstract] [Full Text] [Related]

  • 20. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A, Janicki K, Pietura R, Janicka L.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Jan 30; 58(1):248-53. PubMed ID: 15314994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.